The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

Communicable diseases news

Read our latest news items related to communicable diseases.

News

2021 National NAIDOC Awards

The National NAIDOC Awards are an opportunity to recognise outstanding achievements by Aboriginal and Torres Strait Islander people at the community, national and international level.

It’s beginning to look a lot like Christmas…

2021 is quickly coming to an end. With the holidays just around the corner, a lot of us will be travelling interstate and visiting family and friends.

COVID-19 – Omicron update from CMO Professor Paul Kelly

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

COVID-19 – Omicron update from CMO Professor Paul Kelly

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Australian Technical Advisory Group on Immunisation (ATAGI) recommendations on the use of Spikevax (Moderna) as a COVID-19 booster vaccine

Spikevax (Moderna), also referred to as the Moderna COVID-19 vaccine, has been provisionally approved for use as a COVID-19 booster vaccine in people aged 18 years and older by the Therapeutic Goods Administration (TGA).

ATAGI statement on the Omicron variant and timing of COVID-19 booster vaccination

The COVID-19 vaccines used in Australia are critical in protecting against COVID-19 due to all variants, including the newly emerged Omicron variant.

Response to ATAGI advice about vaccinating 5 to 11-year-olds against COVID-19

The latest phase in our COVID-19 vaccination rollout program – to vaccinate children aged 5 to 11 years from 10 January 2022 – continues to be based on the best medical and scientific advice available.

Australia vaccinating children against COVID-19 from early next year

Australia’s COVID-19 vaccination program will be extended to all children aged 5 to 11 from 10 January 2022 after the Australian Government accepted recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI).

ATAGI update following weekly COVID-19 meeting – 8 December 2021

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 8 December 2021.

ATAGI recommendations on Pfizer COVID-19 vaccine use in children aged 5 to 11 years

The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Pfizer COVID-19 vaccine in children aged 5 to 11 years.

COVID-19 – Omicron update from CMO Professor Paul Kelly

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern.

Updated ATAGI advice on the administration of seasonal influenza vaccines in 2021 (December 2021)

As international borders open, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued updated advice for the rollout of influenza vaccines.

AHPPC statement on national principles for end-to-end best practice managed quarantine arrangements for international travellers

A statement from the Australian Health Protection Principal Committee (AHPPC) on managed quarantine arrangements for international travellers.

COVID-19 vaccination information kiosks open now in Qld and WA

COVID-19 vaccination information kiosks are now open in shopping centres and events in Queensland and Western Australia to help you book a vaccination appointment.

TGA provisionally approves Pfizer COVID-19 vaccine for 5 to 11-year-olds

The Therapeutic Goods Administration (TGA) provisionally approved the Comirnaty Paediatric (Pfizer) COVID-19 vaccine for 5 to 11-year-olds on 5 December 2021.  

Chief Medical Officer, Professor Paul Kelly – COVID-19 Omicron update

An update from Australia's Chief Medical Officer, Professor Paul Kelly, about the new Omicron variant of concern

ATAGI update following weekly COVID-19 meeting – 1 December 2021

An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 1 December 2021.

ATAGI statement on SARS-CoV-2 Omicron variant and COVID-19 booster doses

The Australian Technical Advisory Group on Immunisation (ATAGI) has noted the emergence of a new SARS-CoV-2 variant of concern, which has been named the Omicron variant.
Date last updated:

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.